TY - JOUR
T1 - IL-12-dependent cytomegalovirus-specific CD4+ T cell proliferation, T-bet induction, and effector multifunction during primary infection are key determinants for early immune control
AU - Popescu, Iulia
AU - Pipeling, Matthew R.
AU - Mannem, Hannah
AU - Shah, Pali D.
AU - Orens, Jonathan B.
AU - Connors, Mark
AU - Migueles, Stephen A.
AU - McDyer, John F.
N1 - Funding Information:
This work was supported by National Institutes of Health Grant R01-AI079175 (to J.F.M.).
Publisher Copyright:
© 2016 by The American Association of Immunologists, Inc.
PY - 2016/1/15
Y1 - 2016/1/15
N2 - MV remains an important opportunistic pathogen in solid organ and hematopoietic cell transplantation, particularly in lung transplant recipients (LTRs). LTRs mismatched for CMV (donor+/recipient-; D+R-) are at high risk for active CMVinfection and increased mortality; however, the immune correlates of viral control remain incompletely understood. We prospectively studied 27 D+R- LTRs during primary CMV infection to determine whether acute CD4+ T cell parameters differentiated the capacity for viral control during early chronic infection. Unexpectedly, the T-box transcription factor, T-bet, was expressed at low levels in CD4+ compared with CD8+ T cells during acute primary infection. However, the capacity for in vitro CMV phosphoprotein 65-specific proliferation and CD4+ T-bet+ induction differentiated LTR controllers from early viremic relapsers, correlating with granzyme B loading and effector multifunction. Furthermore, impaired CMV-specific proliferative responses from relapsers, along with T-bet, and effector function could be significantly rescued, most effectively with phosphoprotein 65 Ag and combined exogenous IL-2 and IL-12. Acute CD4+ T cell CMV-specific proliferative and effector responses were highly IL-12-dependent in blocking studies. In addition, we generated monocyte-derived dendritic cells using PBMC obtained during primary infection from relapsers and observed impaired monocytederived dendritic cell differentiation, a reduced capacity for IL-12 production, but increased IL-10 production compared with controls, suggesting an APC defect during acute CMV viremia. Taken together, these data show an important role for CMV-specific CD4+ effector responses in differentiating the capacity of high-risk LTRs to establish durable immune control during early chronic infection and provide evidence for IL-12 as a key factor driving these responses.
AB - MV remains an important opportunistic pathogen in solid organ and hematopoietic cell transplantation, particularly in lung transplant recipients (LTRs). LTRs mismatched for CMV (donor+/recipient-; D+R-) are at high risk for active CMVinfection and increased mortality; however, the immune correlates of viral control remain incompletely understood. We prospectively studied 27 D+R- LTRs during primary CMV infection to determine whether acute CD4+ T cell parameters differentiated the capacity for viral control during early chronic infection. Unexpectedly, the T-box transcription factor, T-bet, was expressed at low levels in CD4+ compared with CD8+ T cells during acute primary infection. However, the capacity for in vitro CMV phosphoprotein 65-specific proliferation and CD4+ T-bet+ induction differentiated LTR controllers from early viremic relapsers, correlating with granzyme B loading and effector multifunction. Furthermore, impaired CMV-specific proliferative responses from relapsers, along with T-bet, and effector function could be significantly rescued, most effectively with phosphoprotein 65 Ag and combined exogenous IL-2 and IL-12. Acute CD4+ T cell CMV-specific proliferative and effector responses were highly IL-12-dependent in blocking studies. In addition, we generated monocyte-derived dendritic cells using PBMC obtained during primary infection from relapsers and observed impaired monocytederived dendritic cell differentiation, a reduced capacity for IL-12 production, but increased IL-10 production compared with controls, suggesting an APC defect during acute CMV viremia. Taken together, these data show an important role for CMV-specific CD4+ effector responses in differentiating the capacity of high-risk LTRs to establish durable immune control during early chronic infection and provide evidence for IL-12 as a key factor driving these responses.
UR - http://www.scopus.com/inward/record.url?scp=84954182648&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84954182648&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1501589
DO - 10.4049/jimmunol.1501589
M3 - Article
C2 - 26663780
AN - SCOPUS:84954182648
SN - 0022-1767
VL - 196
SP - 877
EP - 890
JO - Journal of Immunology
JF - Journal of Immunology
IS - 2
ER -